
Nextki 50mg Tablet
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Dasatinib (50mg)
Overview Nextki 50mg Tablet
Axillary 50mg tablets are indicated for treating chronic myeloid leukemia (a type of blood cancer). This medication is prescribed for individuals whose leukemia hasn't responded to other treatments or who experience intolerable side effects from alternative therapies. Axillary 50mg tablets may be ingested with or without food, but consistent daily timing maximizes therapeutic efficacy. Dosage and frequency are determined by your physician based on your specific condition and may be adjusted. Strictly adhere to your doctor's instructions; improper usage or overdosing can lead to severe adverse reactions. While therapeutic effects might not be immediately apparent (weeks or months may pass), discontinue use only under your doctor's guidance. Common side effects include nausea, vomiting, stomach pain, and skin rashes. Increased heart rate and blood pressure fluctuations (both high and low) are possible; consult your physician immediately if these occur. Regular blood pressure monitoring may be implemented. Avoid antacids within two hours of administration. This medication can decrease blood cell counts, raising infection risk; regular blood tests are essential. Inform your healthcare provider about all medications you're taking, as interactions are possible. This medicine is contraindicated during pregnancy and breastfeeding. Refrain from driving if dizziness or visual disturbances arise.
Uses of Nextki 50mg Tablet
Chronic myelogenous leukemia, a type of blood malignancy.
Major Benefits of Nextki 50mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Nextki 50mg tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Nextki 50mg Tablet:
- Abdominal pain
- Anemia (low number of red blood cells)
- Breathing problems
- Fatigue
- Fever
- Headache
- Infection
- Low blood platelets
- Musculoskeletal (bone, muscle or joint) pain
- Nausea
- Rash
- Vomiting
How to use Nextki 50mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Nextki 50mg tablets can be administered with or without food, though consistent timing is recommended.
How Nextki 50mg Tablet works:
Nextia 50mg tablets are an anti-neoplastic agent. Their mechanism of action involves inhibiting the activity of a faulty protein responsible for triggering cancerous cell proliferation, thus hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Nextki 50mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Nextki 50mg tablets during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Administration of Nextki 50mg tablets is contraindicated while breastfeeding. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Nextki 50mg Tablet side effects. Exercise caution while driving if dizziness or blurred vision occurs after taking Nextki 50mg Tablet.
KidneySAFE IF PRESCRIBED
Nextki 50mg tablets are likely safe for individuals with kidney impairment. Existing evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Nextki 50mg tablets can be administered to patients with hepatic impairment without the need for dosage modification.
What if you forget to take Nextki 50mg Tablet :
Omit any missed Nextki 50mg Tablet dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Nextki 50mg Tablet
Label | Value |
---|---|
Chemical Type | Pyrimidine and Thiazole Derivatives |
Developing Habits | No. |
Treatment Category | Cancer Medications |
Behavior Class | Kinase inhibitors targeting tyrosine |